Timur Cerić

481 total citations
23 papers, 163 citations indexed

About

Timur Cerić is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Timur Cerić has authored 23 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Timur Cerić's work include Breast Cancer Treatment Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Timur Cerić is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Timur Cerić collaborates with scholars based in Bosnia and Herzegovina, Serbia and Spain. Timur Cerić's co-authors include S. Beslija, Emir Sokolović, Semir Vranić, Amina Kurtović-Kozarić, Vera Hirsh, Safi R. Bahcall, Vojislav Vukovic, Ermina Mujičić, Fadlo R. Khuri and Bojan Zarić and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Timur Cerić

20 papers receiving 160 citations

Peers

Timur Cerić
Nam-Sun Paik South Korea
Andrea Jewell United States
Lindsay F. Petersen United States
Penny Coulson United Kingdom
Sarah V. Colonna United States
Hongyun Gong China
Odair Carlito Michelin Brazil
Blair McNamara United States
Mary Kay Barton Canada
Michelle Brotzman United States
Nam-Sun Paik South Korea
Timur Cerić
Citations per year, relative to Timur Cerić Timur Cerić (= 1×) peers Nam-Sun Paik

Countries citing papers authored by Timur Cerić

Since Specialization
Citations

This map shows the geographic impact of Timur Cerić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timur Cerić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timur Cerić more than expected).

Fields of papers citing papers by Timur Cerić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timur Cerić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timur Cerić. The network helps show where Timur Cerić may publish in the future.

Co-authorship network of co-authors of Timur Cerić

This figure shows the co-authorship network connecting the top 25 collaborators of Timur Cerić. A scholar is included among the top collaborators of Timur Cerić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timur Cerić. Timur Cerić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hochmair, Maximilian J., Mojca Unk, Timur Cerić, et al.. (2024). Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability. BMC Proceedings. 18(S3). 2–2.
3.
Sokolović, Emir, et al.. (2023). Real-world treatment patterns and outcomes in patients with metastatic melanoma. SHILAP Revista de lepidopterología. 151(3-4). 209–215. 1 indexed citations
4.
Cerić, Timur, et al.. (2022). Guidelines for breast cancer management in Bosnia and Herzegovina. SHILAP Revista de lepidopterología. 23(1). 2–14. 2 indexed citations
5.
Cerić, Timur, et al.. (2022). The Oncology Association of Bosnia and Herzegovina's Recommendations for Fertility Preservation in Oncologic Patients. Bosnian Journal of Basic Medical Sciences. 22(5). 646–650. 1 indexed citations
6.
Sokolović, Emir, et al.. (2022). Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib. SHILAP Revista de lepidopterología. 23(1). 161–169. 3 indexed citations
7.
8.
Cerić, Timur, Marko Jakopović, Santiago Ponce Aix, et al.. (2021). 1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression. Annals of Oncology. 32. S1166–S1166. 2 indexed citations
9.
10.
Sokolović, Emir, et al.. (2020). The Prognostic Value of SUVmax of 18F-FDG PET/CT in Patients with Metastatic Colorectal Cancer. Acta Medica Academica. 49(1). 1–1. 8 indexed citations
11.
Andrić, Zoran, Timur Cerić, Marko Jakopović, et al.. (2020). Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924. European Journal of Cancer. 138. S5–S5. 1 indexed citations
12.
Cerić, Timur, et al.. (2019). Letrozole-induced hepatitis in 42-year-old woman with invasive ductal breast cancer. The Turkish Journal of Gastroenterology. 30(Supp1). 30–30. 4 indexed citations
13.
Bilalović, Nurija, et al.. (2018). A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience. The Breast Journal. 24(6). 1105–1108. 11 indexed citations
14.
Kurtović-Kozarić, Amina, et al.. (2017). Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia. Journal of Global Oncology. 4(4). 1–5. 18 indexed citations
15.
16.
Cerić, Timur, et al.. (2016). Advantages of Combined PET-CT in Mediastinal Staging in Patients with Non-small Cell Lung Carcinoma. Acta Informatica Medica. 24(2). 99–99. 7 indexed citations
17.
Ramalingam, Suresh S., Bojan Zarić, Timur Cerić, et al.. (2014). Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma.. Journal of Clinical Oncology. 32(15_suppl). TPS8118–TPS8118. 5 indexed citations
18.
Ramalingam, Suresh S., Glenwood Goss, Igor Bondarenko, et al.. (2013). A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1).. Journal of Clinical Oncology. 31(15_suppl). CRA8007–CRA8007. 21 indexed citations
19.
Cerić, Timur, et al.. (2010). Investigation of Ivs14+1G>A Polymorphism of Dpyd Gene in a Group of Bosnian Patients Treated with 5-Fluorouracil and Capecitabine. SHILAP Revista de lepidopterología. 10(2). 133–139. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nam-Sun Paik Breakdown of academic impact, for papers by Andrea Jewell Breakdown of academic impact, for papers by Lindsay F. Petersen Breakdown of academic impact, for papers by Penny Coulson Breakdown of academic impact, for papers by Sarah V. Colonna Breakdown of academic impact, for papers by Hongyun Gong Breakdown of academic impact, for papers by Odair Carlito Michelin Breakdown of academic impact, for papers by Blair McNamara Breakdown of academic impact, for papers by Mary Kay Barton Breakdown of academic impact, for papers by Michelle Brotzman
Rankless by CCL
2026